Anavex Life Sciences Corp. (AVXL)

4.10 +0.29 (+7.61%) USD  |  NASDAQ  |  Feb 06, 16:00
4.25 +0.15 (+3.66%) After-Hours: 20:00
More

Anavex Life Sciences SG&A Expense (TTM) : 13.82M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for AVXL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
CorMedix, Inc. 75.56M
Verastem, Inc. 67.48M
Ocugen, Inc. 27.76M
AnaptysBio, Inc. 45.14M
Replimune Group, Inc. 103.07M